Pharma Foods International Co., Ltd. (TYO:2929)

TYO:2929 Balance Sheet

Financials in millions JPY. Fiscal year is August - July.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Cash & Equivalents	8,665	9,157	15,666	16,306	8,845	9,794
Short-Term Investments	100	-	-	-	-	-
Cash & Short-Term Investments	8,765	9,157	15,666	16,306	8,845	9,794
Cash Growth	-15.30%	-41.55%	-3.92%	84.35%	-9.69%	198.42%
Accounts Receivable	4,284	5,285	4,294	4,582	7,425	4,917
Other Receivables	115	-	-	-	-	-
Receivables	4,399	5,285	4,294	4,582	7,425	4,917
Inventory	9,393	7,850	6,717	6,053	6,066	2,748
Other Current Assets	2,449	1,578	598	589	1,177	474
Total Current Assets	25,006	23,870	27,275	27,530	23,513	17,933
Property, Plant & Equipment	4,762	4,696	4,609	4,404	4,458	1,808
Long-Term Investments	2,721	3,446	4,159	3,663	2,881	987
Goodwill	45	71	124	197	270	140
Other Intangible Assets	49	49	53	41	35	45
Long-Term Deferred Tax Assets	1,356	515	351	395	-	-
Other Long-Term Assets	917	2	2	2	2	2
Total Assets	34,856	32,649	36,573	36,232	31,159	20,944

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Accounts Payable	1,587	1,923	1,250	937	1,176	846
Accrued Expenses	166	72	72	72	70	3
Short-Term Debt	16,400	11,400	14,900	17,400	15,400	2,500
Current Portion of Long-Term Debt	560	560	760	955	760	939
Current Income Taxes Payable	302	5,014	5,423	3,992	4,511	5,283
Other Current Liabilities	5,084	1,036	758	1,018	878	1,407
Total Current Liabilities	24,099	20,005	23,163	24,374	22,795	10,978
Long-Term Debt	251	671	1,231	1,741	697	1,458
Pension & Post-Retirement Benefits	381	378	384	320	427	16
Other Long-Term Liabilities	42	49	210	167	168	28
Total Liabilities	24,773	21,103	24,988	26,602	24,087	12,480

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Common Stock	2,043	2,043	2,043	2,043	2,042	2,038
Additional Paid-In Capital	1,814	1,814	1,814	1,814	1,820	1,817
Retained Earnings	5,919	7,691	8,356	5,792	3,300	4,599
Treasury Stock	-26	-195	-1,194	-343	-138	-
Comprehensive Income & Other	333	193	566	324	46	10
Total Common Equity	10,083	11,546	11,585	9,630	7,070	8,464
Minority Interest	-	-	-	-	2	-
Shareholders' Equity	10,083	11,546	11,585	9,630	7,072	8,464
Total Liabilities & Equity	34,856	32,649	36,573	36,232	31,159	20,944

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Total Debt	17,211	12,631	16,891	20,096	16,857	4,897
Net Cash (Debt)	-8,446	-3,474	-1,225	-3,790	-8,012	4,897
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-290.81	-120.87	-43.07	-131.25	-276.14	168.47
Filing Date Shares Outstanding	29.04	28.87	28.07	28.85	29.02	28.95
Total Common Shares Outstanding	29.04	28.87	28.07	28.85	29.02	29.06
Working Capital	907	3,865	4,112	3,156	718	6,955
Book Value Per Share	347.17	399.90	412.69	333.85	243.61	291.24
Tangible Book Value	9,989	11,426	11,408	9,392	6,765	8,279
Tangible Book Value Per Share	343.93	395.75	406.38	325.60	233.10	284.87
Order Backlog	-	600	1,012	1,558	1,300	63

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error